Antivirals for pandemic influenza : guidance on developing a distribution and dispensing program / Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.

Format:

Book

Author/Creator:

Institute of Medicine (U.S.). Committee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic.

Contributor:

Institute of Medicine (U.S.). Board on Population Health and Public Health Practice.

Language:

English

Subjects (All):

Antiviral agents--Effectiveness.

Antiviral agents.

Epidemics--Prevention.

Epidemics.

Influenza--Prevention.

Influenza.

Influenza, Human--prevention & control.

Antiviral Agents--supply & distribution.

Program Development--methods.

Antiviral Agents--therapeutic use.

Disease Outbreaks--prevention & control.

Medical Subjects:

Influenza, Human--prevention & control.

Antiviral Agents--supply & distribution.

Program Development--methods.

Antiviral Agents--therapeutic use.

Disease Outbreaks--prevention & control.

Physical Description:

1 online resource (x, 122 pages)

Edition:

1st ed.

Place of Publication:

Washington, DC : National Academies Press, c2008.

Language Note:

English

Summary:

Planning for an influenza pandemic, whether it occurs in the near or distant future, will need to take into account many constantly evolving factors. The Institute of Medicine (IOM) Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic was asked by the Department of Health and Human Services, (DHHS) to consider best practices and policies for providing antiviral treatment and prophylaxis during a pandemic event. The committee (TM)s report, entitled Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program, calls for a national and public process of creating an ethical framework for antiviral use within the context of uncertainty and scarcity. It is unclear whether antivirals will work against a pandemic strain as well as they work against seasonal influenza. Also, government stockpiles may not be sufficient for all possible uses in part because antivirals are costly and public health agencies must invest in other important activities, including other medical resources for pandemic influenza. Furthermore, the report identifies the lack of a science-based advisory body to guide decision making during the pandemic, including guidance on all dimensions of antiviral dispensing (for example, prioritization, drug safety, and antiviral resistance). The report also acknowledges the need for diverse methods and sites of dispensing, and discusses their advantages and disadvantages.

Contents:

Introduction

Antiviral effectiveness, safety, and supply

Ethics, decision making, and communication

Who should get antivirals and where?

Notes:

Description based upon print version of record.

Includes bibliographical references.

Other Format:

Print version: Institute of Medicine (U.S.). Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic. Antivirals for pandemic influenza.

ISBN:

9786611767525

9780309185691

0309185696

9781281767523

1281767522

9780309118675

0309118670

OCLC:

923279005